Fulvestrant alleviates cisplatin-induced acute kidney injury via repression of BNIP3-mediated apoptosis and autophagy
Journal of Pharmacy and Pharmacology · 2024
DOI: 10.1093/jpp/rgad094 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2024. Verfasst von Hui-Ju Lee und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Medicine & Institute of Veterinary Science, Chungnam National University, Daejeon 34134, Republic of Korea. Hauptthemen laut MEDLINE: Cisplatin, Acute Kidney Injury, Fulvestrant, Autophagy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea, Ministry of Education.
Abstract (Originalsprache)
Cisplatin-induced acute kidney injury (AKI) is a clinical disease characterized by a sudden loss of renal function within a few hours or days, due to cisplatin uptake. Fulvestrant is an oestrogen receptor alpha (ERα) antagonist used for endocrine therapy. However, the role of fulvestrant in cisplatin-induced AKI remains unclear. In this study, we investigated the effects of fulvestrant on the regulation of apoptotic cell death and autophagic response in cisplatin-induced AKI. The human kidney proximal tubule epithelial cell line (HK-2) was co-treated with fulvestrant and cisplatin. C57BL/6 mice were subcutaneously injected with fulvestrant and cisplatin was administered via intraperitoneal injection. First, cisplatin treatment increased ERα expression, apoptosis, and autophagy in HK-2 cells. Fulvestrant treatment decreased apoptosis and autophagy, which were accompanied by cisplatin treatment in HK-2 cells. Consistent with in vitro results, cisplatin treatment significantly increased ERα expression in vivo. Additionally, cisplatin treatment increased renal injury, apoptosis, and autophagy. Surprisingly, compared to that in the cisplatin-treated mice group, reduced cisplatin-induced renal injury, apoptosis, and autophagy was observed in the cisplatin+fulvestrant-treated mice group. In summary, these results suggest that fulvestrant plays an important role in cisplatin-induced AKI by decreasing apoptosis and autophagy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Veterinary Medicine & Institute of Veterinary Science, Chungnam National University, Daejeon 34134, Republic of Korea.
- Department of Anatomy, College of Medicine, Konyang University, Daejeon 35365, Republic of Korea.
ORCID-Profile: Ju-Young Jung
Förderung
- National Research Foundation of Korea
- Ministry of Education
Zitieren
APA
Lee, H. J., Kim, Y. J., Kim, K. H., Cho, S. P., Hong, G. L., & Jung, J. Y. (2024). Fulvestrant alleviates cisplatin-induced acute kidney injury via repression of BNIP3-mediated apoptosis and autophagy. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgad094
Vancouver
Lee HJ, Kim YJ, Kim KH, Cho SP, Hong GL, Jung JY. Fulvestrant alleviates cisplatin-induced acute kidney injury via repression of BNIP3-mediated apoptosis and autophagy. Journal of Pharmacy and Pharmacology. 2024. doi:10.1093/jpp/rgad094
BibTeX
@article{Lee2024,
author = {Lee, Hui-Ju and Kim, Yae-Ji and Kim, Kyung-Hyun and Cho, Sung-Pil and Hong, Geum-Lan and Jung, Ju-Young},
title = {Fulvestrant alleviates cisplatin-induced acute kidney injury via repression of BNIP3-mediated apoptosis and autophagy},
journal = {Journal of Pharmacy and Pharmacology},
year = {2024},
doi = {10.1093/jpp/rgad094}
}
EUVIMED